亚临床甲减:到底要不要补充甲状腺激素?

2018-12-17 dr. 苹果 医咖会

亚临床甲状腺功能减退症是指促甲状腺激素(TSH)水平升高,而游离甲状腺激素水平处于正常范围。这一情况在女性及老年人中高发,患者可能会给予甲状腺激素治疗,尤其对于具有明显甲状腺功能低下症状的患者。但是,关于在这些人群中给予甲状腺激素治疗的临床获益,目前暂不明确。今天要跟大家分享的是近期在JAMA杂志上发表的一篇荟萃分析,探讨甲状腺激素治疗是否能改善亚临床甲减患者的生活质量及相关症状。研究目的本研究是

临床甲状腺功能减退症是指促甲状腺激素(TSH)水平升高,而游离甲状腺激素水平处于正常范围。这一情况在女性及老年人中高发,患者可能会给予甲状腺激素治疗,尤其对于具有明显甲状腺功能低下症状的患者。但是,关于在这些人群中给予甲状腺激素治疗的临床获益,目前暂不明确。

今天要跟大家分享的是近期在JAMA杂志上发表的一篇荟萃分析,探讨甲状腺激素治疗是否能改善亚临床甲减患者的生活质量及相关症状。

研究目的

本研究是一项荟萃分析,旨在探讨亚临床甲减的非妊娠患者补充甲状腺激素是否能改善一般生活质量或甲状腺相关症状。

研究方法

纳入在非妊娠成人中比较甲状腺激素与安慰剂/无治疗的研究。

主要研究终点为随访至少3个月以上的一般生活质量(General quality of life)及甲状腺相关症状。

研究结果

共选取21项随机临床研究(RCT),涉及2192例患者。

1. TSH水平

较安慰剂相比,甲状腺激素治疗(随访时间为3-18个月)后TSH水平显着下降到正常范围(4.6-14.7mIU/L vs 0.5-3.7mIU/L)。

2. 一般生活质量、甲状腺相关症状及其他心情相关症状

甲状腺激素治疗较安慰剂相比并没有显着改善患者的一般生活质量(标准化平均差异SMD = 0.11, 95% CI -0.25 to 0.03)及甲状腺相关症状(SMD = 0.01, 95%CI -0.12 to -0.14)。

在抑郁症状方面,甲状腺激素治疗较安慰剂相比并同样没有得到显着改善(SMD=-0.10,95% CI -0.34-0.13)。

3. 认知功能

较安慰剂相比,甲状腺激素治疗并没有显着改善患者的认知功能(SMD=-0.09,95% CI -0.05-0.22)。

4. 收缩压

较安慰剂相比,甲状腺激素治疗并没有显着改善患者的收缩压(平均相差-0.07mmHg, 95% CI -2.6 to 1.2mmHg)。

5. 体重指数BMI

较安慰剂相比,甲状腺激素治疗后患者的BMI并没有明显的改变(平均相差0.2,95% CI -0.4-0.8)。

研究质量

纳入的21项研究的总体质量较高,偏倚风险处于低水平,通过GRADE工具评估的证据质量裁定为中-高水平。

研究结论

在非妊娠的亚临床甲减成人患者中,甲状腺激素的使用并没有使一般生活质量及甲状腺相关症状得到改善,这一研究并不支持亚临床甲减患者甲状腺激素的常规使用。

研究者指出,尽管目前指南提示亚临床甲减的治疗需要慎重,但实际上有相当一部分TSH<10mIU/L的患者会给予甲状腺激素补充治疗,但是,本次荟萃分析的结果与目前的指南推荐并不一致。

研究者也承认了该研究中的几个局限性,包括不同的研究采用的问卷调查方式不同,治疗时间不一。但是他们发现不同研究之间,除了一般生活治疗及BMI情况外,其他方面的异质性较低。另外,本次荟萃分析纳入的大部分研究的基线TSH均<10mIU/L,因此,目前的研究结论并不适用于TSH≥10mIU/L的亚临床甲减患者。

总的来说,目前研究并没有看到在亚临床甲减患者中给予甲状腺激素治疗能改善患者的一般生活质量及甲状腺相关症状。

参考文献:JAMA. 2018; 320(13):1349-59

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=944217, encodeId=f6df94421eba, content=我家三岁半女孩先天性亚临床甲减,无明显症状,能吃能玩的精神状态都很好。从一个月开始给予优甲乐治疗,现在每天己经增加到二分之一的量了。现在甲功五项中仍然只有tah高,但小于10!, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db45463945, createdName=ms3000001504157755, createdTime=Sun Feb 28 15:45:48 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363691, encodeId=a98e36369147, content=谢谢,这方便还需要研究下,在临床中我都是结合病人的情况选择是否用药的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:12:45 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363690, encodeId=d87e36369070, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:11:50 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341320, encodeId=d1bb1341320a5, content=<a href='/topic/show?id=0cb769e593b' target=_blank style='color:#2F92EE;'>#甲减#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69759, encryptionId=0cb769e593b, topicName=甲减)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d47b2500175, createdName=12498cf9m35(暂无昵称), createdTime=Wed Dec 19 11:46:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355770, encodeId=4fa9355e70e2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 18 22:04:21 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050225, encodeId=92a0105022599, content=大家一般关心疾病,但是亚临床更重要,这是疾病防控方向的前移,各类疾病都是这样。如亚临床甲减,亚临床心肌损伤,亚临床心衰等, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jingjing, createdTime=Mon Dec 17 23:46:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]
    2021-02-28 ms3000001504157755

    我家三岁半女孩先天性亚临床甲减,无明显症状,能吃能玩的精神状态都很好。从一个月开始给予优甲乐治疗,现在每天己经增加到二分之一的量了。现在甲功五项中仍然只有tah高,但小于10!

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=944217, encodeId=f6df94421eba, content=我家三岁半女孩先天性亚临床甲减,无明显症状,能吃能玩的精神状态都很好。从一个月开始给予优甲乐治疗,现在每天己经增加到二分之一的量了。现在甲功五项中仍然只有tah高,但小于10!, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db45463945, createdName=ms3000001504157755, createdTime=Sun Feb 28 15:45:48 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363691, encodeId=a98e36369147, content=谢谢,这方便还需要研究下,在临床中我都是结合病人的情况选择是否用药的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:12:45 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363690, encodeId=d87e36369070, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:11:50 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341320, encodeId=d1bb1341320a5, content=<a href='/topic/show?id=0cb769e593b' target=_blank style='color:#2F92EE;'>#甲减#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69759, encryptionId=0cb769e593b, topicName=甲减)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d47b2500175, createdName=12498cf9m35(暂无昵称), createdTime=Wed Dec 19 11:46:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355770, encodeId=4fa9355e70e2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 18 22:04:21 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050225, encodeId=92a0105022599, content=大家一般关心疾病,但是亚临床更重要,这是疾病防控方向的前移,各类疾病都是这样。如亚临床甲减,亚临床心肌损伤,亚临床心衰等, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jingjing, createdTime=Mon Dec 17 23:46:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]
    2019-03-28 1256780dm51暂无昵称

    谢谢,这方便还需要研究下,在临床中我都是结合病人的情况选择是否用药的。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=944217, encodeId=f6df94421eba, content=我家三岁半女孩先天性亚临床甲减,无明显症状,能吃能玩的精神状态都很好。从一个月开始给予优甲乐治疗,现在每天己经增加到二分之一的量了。现在甲功五项中仍然只有tah高,但小于10!, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db45463945, createdName=ms3000001504157755, createdTime=Sun Feb 28 15:45:48 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363691, encodeId=a98e36369147, content=谢谢,这方便还需要研究下,在临床中我都是结合病人的情况选择是否用药的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:12:45 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363690, encodeId=d87e36369070, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:11:50 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341320, encodeId=d1bb1341320a5, content=<a href='/topic/show?id=0cb769e593b' target=_blank style='color:#2F92EE;'>#甲减#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69759, encryptionId=0cb769e593b, topicName=甲减)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d47b2500175, createdName=12498cf9m35(暂无昵称), createdTime=Wed Dec 19 11:46:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355770, encodeId=4fa9355e70e2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 18 22:04:21 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050225, encodeId=92a0105022599, content=大家一般关心疾病,但是亚临床更重要,这是疾病防控方向的前移,各类疾病都是这样。如亚临床甲减,亚临床心肌损伤,亚临床心衰等, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jingjing, createdTime=Mon Dec 17 23:46:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]
    2019-03-28 1256780dm51暂无昵称

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=944217, encodeId=f6df94421eba, content=我家三岁半女孩先天性亚临床甲减,无明显症状,能吃能玩的精神状态都很好。从一个月开始给予优甲乐治疗,现在每天己经增加到二分之一的量了。现在甲功五项中仍然只有tah高,但小于10!, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db45463945, createdName=ms3000001504157755, createdTime=Sun Feb 28 15:45:48 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363691, encodeId=a98e36369147, content=谢谢,这方便还需要研究下,在临床中我都是结合病人的情况选择是否用药的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:12:45 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363690, encodeId=d87e36369070, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:11:50 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341320, encodeId=d1bb1341320a5, content=<a href='/topic/show?id=0cb769e593b' target=_blank style='color:#2F92EE;'>#甲减#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69759, encryptionId=0cb769e593b, topicName=甲减)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d47b2500175, createdName=12498cf9m35(暂无昵称), createdTime=Wed Dec 19 11:46:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355770, encodeId=4fa9355e70e2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 18 22:04:21 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050225, encodeId=92a0105022599, content=大家一般关心疾病,但是亚临床更重要,这是疾病防控方向的前移,各类疾病都是这样。如亚临床甲减,亚临床心肌损伤,亚临床心衰等, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jingjing, createdTime=Mon Dec 17 23:46:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=944217, encodeId=f6df94421eba, content=我家三岁半女孩先天性亚临床甲减,无明显症状,能吃能玩的精神状态都很好。从一个月开始给予优甲乐治疗,现在每天己经增加到二分之一的量了。现在甲功五项中仍然只有tah高,但小于10!, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db45463945, createdName=ms3000001504157755, createdTime=Sun Feb 28 15:45:48 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363691, encodeId=a98e36369147, content=谢谢,这方便还需要研究下,在临床中我都是结合病人的情况选择是否用药的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:12:45 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363690, encodeId=d87e36369070, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:11:50 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341320, encodeId=d1bb1341320a5, content=<a href='/topic/show?id=0cb769e593b' target=_blank style='color:#2F92EE;'>#甲减#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69759, encryptionId=0cb769e593b, topicName=甲减)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d47b2500175, createdName=12498cf9m35(暂无昵称), createdTime=Wed Dec 19 11:46:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355770, encodeId=4fa9355e70e2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 18 22:04:21 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050225, encodeId=92a0105022599, content=大家一般关心疾病,但是亚临床更重要,这是疾病防控方向的前移,各类疾病都是这样。如亚临床甲减,亚临床心肌损伤,亚临床心衰等, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jingjing, createdTime=Mon Dec 17 23:46:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]
    2018-12-18 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=944217, encodeId=f6df94421eba, content=我家三岁半女孩先天性亚临床甲减,无明显症状,能吃能玩的精神状态都很好。从一个月开始给予优甲乐治疗,现在每天己经增加到二分之一的量了。现在甲功五项中仍然只有tah高,但小于10!, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db45463945, createdName=ms3000001504157755, createdTime=Sun Feb 28 15:45:48 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363691, encodeId=a98e36369147, content=谢谢,这方便还需要研究下,在临床中我都是结合病人的情况选择是否用药的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:12:45 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363690, encodeId=d87e36369070, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=766a2562624, createdName=1256780dm51暂无昵称, createdTime=Thu Mar 28 11:11:50 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1341320, encodeId=d1bb1341320a5, content=<a href='/topic/show?id=0cb769e593b' target=_blank style='color:#2F92EE;'>#甲减#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69759, encryptionId=0cb769e593b, topicName=甲减)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d47b2500175, createdName=12498cf9m35(暂无昵称), createdTime=Wed Dec 19 11:46:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355770, encodeId=4fa9355e70e2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 18 22:04:21 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050225, encodeId=92a0105022599, content=大家一般关心疾病,但是亚临床更重要,这是疾病防控方向的前移,各类疾病都是这样。如亚临床甲减,亚临床心肌损伤,亚临床心衰等, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=jingjing, createdTime=Mon Dec 17 23:46:00 CST 2018, time=2018-12-17, status=1, ipAttribution=)]
    2018-12-17 jingjing

    大家一般关心疾病,但是亚临床更重要,这是疾病防控方向的前移,各类疾病都是这样。如亚临床甲减,亚临床心肌损伤,亚临床心衰等

    0

相关资讯

N Engl J Med:孕期亚临床甲减或低甲状腺素血症:是否服药治疗是个问题!

左旋甲状腺素可由胃肠道吸收,但吸收不完全,吸收率不定,特别是在与食物同服时。2017年3月,发表在《N Engl J Med》的研究对怀孕期间被认定为患有亚临床甲状腺功能减退症或低甲状腺素血症的妇女使用左旋甲状腺素治疗是否会改善其孩子的认知功能进行了实验分析。背景:怀孕期间亚临床甲状腺疾病可能与不良结局有关,包括后代智商低于正常水平。在怀孕期间被认定为患有亚临床甲状腺功能减退症或低甲状腺素血症的妇

Thyroid:孕妇亚甲减对妊娠结局危害多

目前关于孕妇亚临床甲减 (SCH) 和左旋甲状腺素替代治疗对妊娠结局的影响仍不明确,因此研究者检索了MEDLINE、EMBASE等数据库,获取相关文献矜持系统回顾和荟萃分析,以评估孕期SCH和左旋甲状腺素替代治疗对妊娠结局的影响。最终共纳入了18篇研究,研究数据显示,与甲工正常的孕妇相比,SCH孕妇有更高的妊娠丢失风险 (RR 2.01, CI 1.66 to 2.44)、胎盘破裂风险(RR 2.

JAMA刊登研究质疑指南:亚临床甲减患者补充甲状腺激素没有益处,未改善症状和生活质量

如果感到疲倦、便秘以及不能解释的体重增加,这或许是被亚临床甲状腺功能减退(甲减)缠上了。这种病很常见,尤其是在女性和老人中更为多见。目前指南给予的推荐,是应用甲状腺激素,不过给予甲状腺激素治疗就解决问题了?近日发表在JAMA上的一项对21项随机对照试验进行的Meta分析结果对此表示了否定。研究显示,亚临床甲减患者常规接受甲状腺激素治疗约3~18个月后,虽然与安慰剂相比,促甲状腺激素下降,但对生活质